Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Amber Yates, MD
Healthcare Provider Associate Director
Pediatric Hematology-Oncology Fellowship Program
Texas Children's Hospital
6701 Fannin Street
Suite 1580
Houston, Texas, United States
Dr. Amber Yates is an Associate Director of the Pediatric Hematology-Oncology Fellowship Program. She is also Co-Director of the Sickle Cell Program, a member of the Hematology Center and Associate Professor Of Pediatrics at Baylor College of Medicine.
Her primary clinical interest is in the care of children with sickle cell disease and other hemoglobin disorders. She is particularly interested in the role of hydroxyurea therapy in improving the lives of children with sickle cell disease, as well as the long term safety and efficacy of hydroxyurea. Her other clinical interests include: hemoglobinopathies and hemolytic anemia.
Dr. Amber Yates is also interested in assisting teenage patients with hematologic disorders so they can achieve a successful transition to adult care.
Representative Publications:
Hydroxyurea treatment of children with hemoglobin SC disease
+myBinderRelated Content
-
Elyse Mandell, MSN, RNCSElyse Mandell is the Nurse Director and ...
-
David Beidler, PhDAs the Translational Sciences lead for t...
-
New England Pediatric Sickle Cell ConsortiumThe New England Pediatric Sickle Cell Co...
-
Home Oxygen Therapy for Children: An Official American Thoracic Society Clinical Practice GuidelineBackground: Home oxygen therapy is ofte...
-
The Sickle Cell & Hemoglobinopathy Center of Western New YorkThe Sickle Cell & Hemoglobinopathy C...
-
Sancilio Pharmaceuticals Company, Inc. (SPCI) Receives Rare Pediatric Disease Designation From the US Food and Drug ...Sancilio Pharmaceuticals Company, Inc. (...
-
Fighting Painful Misconceptions About Sickle Cell Disease in the ERWhen sickle cell patients arrive at emer...
